ABSTRACT
Many effective treatments for scleroderma have emerged in recent years, including bosentan, an endothelin receptor antagonist, and epoprostenol, a prostacyclin, both of which target vasoconstriction. Cyclophosphamide may soon be proven effective against interstitial lung disease.
- Copyright © 2003 The Cleveland Clinic Foundation. All Rights Reserved.
View Abstract
